​
Login / Signup
Meggie N Young
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 2
Top Topics
Tyrosine Kinase
Adverse Drug
Estrogen Receptor
High Throughput
Top Venues
Cancer research
Cancer research communications
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Junkai Wang
,
Alexander B Saltzman
,
Eric J Jaehnig
,
Jonathan T Lei
,
Anna Malovannaya
,
Matthew V Holt
,
Meggie N Young
,
Mothaffar F Rimawi
,
Foluso O Ademuyiwa
,
Meenakshi Anurag
,
Beom-Jun Kim
,
Matthew J Ellis
Kinase Inhibitor Pulldown Assay Identifies a Chemotherapy Response Signature in Triple-negative Breast Cancer Based on Purine-binding Proteins.
Cancer research communications
3 (8) (2023)
Xuxu Gou
,
Beom-Jun Kim
,
Meenakshi Anurag
,
Jonathan T Lei
,
Meggie N Young
,
Matthew V Holt
,
Diana Fandino
,
Craig T Vollert
,
Purba Singh
,
Mohammad A Alzubi
,
Anna Malovannaya
,
Lacey Elizabeth Dobrolecki
,
Michael T Lewis
,
Shunqiang Li
,
Charles E Foulds
,
Matthew J Ellis
Kinome reprogramming is a targetable vulnerability in ESR1 fusion-driven breast cancer.
Cancer research
(2023)